Department of Clinical Chemistry, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Biomedical Research Insitute, Foundation for Research and Technology-Hellas, 45110 Ioannina, Greece.
Molecules. 2022 Feb 17;27(4):1362. doi: 10.3390/molecules27041362.
is a perennial shrub from Paraguay that is nowadays widely cultivated, since it is increasingly being utilized as a sugar substitute in various foodstuffs due to its sweetness and minimal caloric content. These properties of the plant's derivatives have spurred research on their biological activities revealing a multitude of benefits to human health, including antidiabetic, anticariogenic, antioxidant, hypotensive, antihypertensive, antimicrobial, anti-inflammatory and antitumor actions. To our knowledge, no recent reviews have surveyed and reported published work solely on the latter. Consequently, our main objective was to present a concise, literature-based review of the biological actions of stevia derivatives in various tumor types, as studied in in vitro and in vivo models of the disease. With global cancer estimates suggesting a 47% increase in cancer cases by 2040 compared to 2020, the data reviewed in this article should provide a better insight into and its products as a means of cancer prevention and therapy within the context of a healthy diet.
甜菊是一种来自巴拉圭的多年生灌木,如今被广泛种植,因为它的甜度和低卡路里含量使其越来越多地被用作各种食品的糖替代品。这些植物衍生物的特性激发了对其生物活性的研究,揭示了对人类健康的多种益处,包括抗糖尿病、抗龋齿、抗氧化、降血压、抗高血压、抗菌、抗炎和抗肿瘤作用。据我们所知,最近没有任何评论调查和报告仅针对后者的已发表工作。因此,我们的主要目标是在疾病的体外和体内模型中,对甜菊衍生物在各种肿瘤类型中的生物作用进行简明的文献综述。全球癌症估计表明,与 2020 年相比,到 2040 年癌症病例将增加 47%,本文中综述的数据应该可以更好地了解甜菊及其产品作为健康饮食背景下癌症预防和治疗的一种手段。